Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma

Cancer Letters

Volumn 102, Issue 1-2, 1996, Pages 73-76

  Bartsch, D ^a,b   Peiffer, S L ^a   Kaleem, Z ^a   Wells Jr , S A ^a   Goodfellow, P J ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Box 8109 ^*  (United States)

Author keywords

C myc oncogene; MXI1 gene; Pancreatic adenocarcinoma

Indexed keywords

DNA;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 0029871958     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04167-5     Document Type: Article

References (26)

1. Evan, G.I. and Littlewood, T.D. (1993) The role of c-myc in cell growth. Curr. Biol., 3, 44-49.
2. DePinho, R.A., Schreiber-Agus, N. and Alt, F.W. (1991) Myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res., 57, 1-45.
3. Dalla-Favera, R., Martinotti, S., Gallo, R.C., Erickson, J. and Groce, C.M. (1983) Translocation and rearrangement of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science, 219, 963-965.
4. Nakasato, F., Sakamoto, H., Mori, M., Hayashi, K., Shimosato, Y., Nishi, M., Takao, S., Nakatani, K., Terada, M. and Sugimura, T. (1984) Amplification of the c-myc oncogene in human stomach cancers. Jpn. J. Cancer Res., 75, 737-742.
5. Shibuya, M., Yokota, J. and Ueyama, Y. (1985) Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Mol. Cell. Biol., 5, 414-418.
6. Little, C.D., Nau, M.M., Carney, D.N., Gazdar, A.F. and Minna, J.D. (1983) Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature, 306, 194-196.
7. Taya, Y., Hosogai, K., Hirohashi, S., Shimosato, Y., Tsuchiya, R., Tsuchida, N., Fushimi, M., Sekiya, T. and Nishimura, S. (1984) A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in human lung cancer. EMBO J., 3, 2943-2946.
8. Kozbor, D. and Croce, C.M. (1984) Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. Cancer Res., 44, 438-441.
9. Yamada, H., Sakamoto, H., Taira, M., Nishimura, S., Shimosato, Y., Terada, M. and Sugimura, T. (1986) Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. Jpn. J. Cancer Res., 77, 373-375.
10. Yuan, L., Tong-hua, L. and Li, S. (1988) Expression of c-myc and N-ras in human hepatocellular carcinoma and pancreatic adenocarcinoma. Chin. Med. J., 101, 523-528.
11. Sandgren, E.P., Quaife, C.J., Paulowitch, A.C., Palmiter, R.D. and Brinster, R.L. (1991) Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc. Natl. Acad. Sci. USA, 88, 93-97.
12. Murre, C., McCaw, P.S. and Baltimore, D. (1989) A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell, 56, 777-783.
13. Lech, K., Anderson, K. and Brent, R. (1988) DNA-bound Fos proteins activate transcription in yeast. Cell, 52, 179-184.
14. Blackwood, E.M. and Eisenman, R.N. (1991) Max: a helixloop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc. Science, 251, 1211-1217.
15. Zervos, A.S., Gyuris, J. and Brent, R. (1993) Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 72, 223-232.
16. Lahoz, E.G., Xu, L., Schreiber-Agus, N. and DePinho, R.A. (1994) Suppression of Myc, but not Ela, transformation activity by Max-associated proteins, Mad and Mxil. Proc. Natl. Acad. Sci. USA, 91, 5503-5507.
17. Shapiro, D.N., Valentine, V., Eagle, L., Yin, X., Morris, S.W. and Prochownik, E.V. (1994) Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. Genomics, 23, 282-285.
18. Hahn, S.A., Seymour, A.B., Hoque, A.T.S., Schutte, M., da Costa, L.T., Redston, M., Caldas, C., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H. and Kern, S.E. (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res., 55, 4670-4675.
19. Wright, D.K. and Manos, M.M. (1990) Sample preparation from paraffin-embedded tissue. In: PCR Protocols: a Guide to Methods and Applications, pp. 153-158. Editors: M.A. Innis, D.H. Gelfand, J.J. Sninsky and T.J. White. Academic Press, San Diego, CA.
20. Eagle, L.R., Yin, X., Brothman, A.R., Williams, B.J., Atkin, N.B. and Prochownik, E.V. (1995) Mutation of the MXI1 gene in prostate cancer. Nature Genet., 9, 249-255.
21. Bartsch, D., Shevlin, D.W., Tung, W.S., Kisker, O., Wells, Jr., S.A. and Goodfellow, P.J. (1995) Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas. Genes Chromosomes Cancer, 14, 189-195.
22. Goodfellow, P.J., Darling, S.M., Thomas, N.S. and Goodfellow, P.N. (1988) A pseudoautosomal gene in man. Science, 234, 740-743.
23. Seymour, A.B., Hruban, R.H., Redston, M., Caldas, C., Powell, S.M., Kinzler, K.W., Yeo, C.J. and Kern, S.E. (1994) Cancer Res., 54, 2761-2764.
24. Johansson, B., Bardi, G., Heim, S., Mandahl, N., Mertens, F., Bak-Jensen, E., Andren-Sandberg, A. and Mitelman, F. (1992) Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer, 69, 1674-1681.
25. Griffin, C.A., Hruban, R.H., Morsberger, L.A., Ellingham, T., Long, P.P., Jaffee, E.M., Hauda, K.M., Bohlander, S.K. and Yeo, C.J. (1995) Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res., 55, 2394-2399.
26. Bartsch, D., Shevlin, D.W., Callery, M.P., Norton, J.A., Wells, Jr., S.A. and Goodfellow, P.J. (1996) Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation J. Natl. Cancer Inst., in press.